611 Shares in HCA Healthcare, Inc. $HCA Bought by Monument Capital Management

Monument Capital Management purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 611 shares of the company’s stock, valued at approximately $234,000.

A number of other hedge funds have also bought and sold shares of the business. Brighton Jones LLC purchased a new stake in HCA Healthcare in the fourth quarter worth $1,021,000. Farther Finance Advisors LLC increased its position in HCA Healthcare by 26.9% in the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock worth $395,000 after buying an additional 242 shares during the last quarter. Pallas Capital Advisors LLC purchased a new stake in HCA Healthcare in the first quarter worth $357,000. GAMMA Investing LLC increased its position in HCA Healthcare by 17.6% in the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock worth $1,704,000 after buying an additional 737 shares during the last quarter. Finally, Simplicity Wealth LLC increased its position in HCA Healthcare by 22.4% in the first quarter. Simplicity Wealth LLC now owns 933 shares of the company’s stock worth $322,000 after buying an additional 171 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Bank of America lifted their price target on HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a research report on Wednesday, September 10th. Barclays lifted their price target on HCA Healthcare from $390.00 to $445.00 and gave the company an “overweight” rating in a research report on Thursday, September 18th. Robert W. Baird lifted their price target on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Finally, JPMorgan Chase & Co. lifted their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $422.31.

HCA Healthcare Stock Down 1.0%

Shares of HCA stock opened at $414.73 on Friday. The business has a 50-day moving average price of $405.12 and a two-hundred day moving average price of $375.58. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $439.01. The firm has a market cap of $97.04 billion, a P/E ratio of 17.43, a price-to-earnings-growth ratio of 1.32 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the previous year, the company posted $5.50 earnings per share. The company’s revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s payout ratio is 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.